<DOC>
	<DOC>NCT03020810</DOC>
	<brief_summary>This is a single patient expanded access, compassionate and non-emergency use study that provides patients with severe asthma, who do not qualify for ongoing clinical trials with dupilumab, access to this investigational treatment.</brief_summary>
	<brief_title>Dupilumab Compassionate Use Study</brief_title>
	<detailed_description>This study is being undertaken to determine whether dupilumab has efficacy in extremely severe asthma, and to allow a very severe asthma patient, who has been tried on nearly every immunosuppressive drug, early access to a potentially effective therapy. The patient will continue in the study indefinitely. Safety will be evaluated and serious adverse events will be reported.</detailed_description>
	<criteria>Sever systemic corticosteroid dependent asthma for more than 5 years Disease other than asthma Circulation eosinophils more than 1500/ul Current smoker or more than 10 pack years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>